Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." What causes SLE? Experts ...

Systemic lupus erythematosus (SLE) is the most common type of lupus, a chronic autoimmune disease. Symptoms include fatigue, joint pain, and rashes across your nose and cheeks. While there’s no ...

SLE’s focus on the Western canon can be traced back to the program’s creation in 1974. According to Sabol, SLE was founded in response to the social upheavals of the 1970s, ...

The median follow-up was 15 months (range, 4 to 29). The mean (±SD) duration of B-cell aplasia was 112±47 days. All the patients with SLE had DORIS remission, all the patients with idiopathic ...

Understanding the global burden of SLE, and the factors that contribute to the considerable variation in its worldwide incidence and prevalence (particularly health disparities, costs, and ...

However, they stress that non-pharmacological options should not replace drug therapy when it is required, and refer readers to the full management recommendations for SLE and SSc. Source: ...

SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

Adicet Bio receives FDA Fast Track designation for ADI-001 for the treatment of refractory systemic lupus erythematosus (SLE) with extrarenal involvement. News release. Adicet Bio.

Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." What causes SLE? Experts ...